Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: clinical specimens
DNA G+C(%): 38
|
Mid T(℃): 35(+)
Bile reaction(%): +
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(1)
ampicillin: Var(MIC50): 6), MIC90: Var(6
benzyl-pen: R(>32)
imipenem: S(0.5)
meropenem: S(0.064)
|
cefoxitin: R(24)
cefpirom: R(256)
ceftazidime: R(256)
cefuroxime: R(256)
cephalothin: R(256)
|
gentamicin: R(256)
netilmycin: R(256)
|
azithromycin: R(16)
erythromycin: R(16)
clarithromycin: R(16)
|
ciprofloxacin: R(32)
ofloxacin: R(8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(0.19)
|
teicoplanin: R(256)
vancomycin: R(48)
|
|
chloramphenicol: Var(MIC50): 4), MIC90: Var(4
metronidazole: S(1.5)
sulfadiazine: R(256)
SXT: S(0.125)
|
clindamycin: S(0.25)
|